ArticleFrontiers in endocrinology2026
Association between neutrophil percentage-to-albumin ratio and bone mineral density and prevalent osteoporosis in patients with type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of osteoporosis and fragility fractures. Chronic low-grade inflammation and nutritional imbalance are key underlying mechanisms. The neutrophil percentage-to-albumin ratio (NPAR) is a novel biomarker reflecting both processes, but its role in osteoporosis remains unclear. This study aimed to investigate the association between NPAR and bone mineral density (BMD), as well as prevalent osteoporosis, in patients with T2DM. Methods: This retrospective cross-sectional study included 259 patients with T2DM. Osteoporosis was diagnosed according to the World Health Organization (WHO) criteria based on dual-energy X-ray absorptiometry results. Logistic regression was used to assess the association between NPAR andprevalent osteoporosis. Linear regression evaluated its relationship with BMD at the femoral neck and total hip. Receiver operating characteristic analysis assessed its concurrent discriminative capacity for prevalent osteoporosis. Results: NPAR levels were higher in the osteoporosis group (P = 0.004). NPAR was independently associated with osteoporosis (OR = 3.42, 95% CI: 1.10-10.64, P = 0.034). It was negatively associated with femoral neck BMD (b = -0.08, 95% CI: -0.14 to -0.02, P = 0.009) and total hip BMD (b = -0.08, 95% CI: -0.14 to -0.01, P = 0.020). The AUC was 0.62 (95% CI: 0.54-0.71, P = 0.004). Conclusion: Given its modest concurrent discriminative ability, NPAR should be interpreted in combination with other clinical indicators rather than used as an independent screening marker for disease diagnosis, but may provide supplementary information regarding prevalent osteoporosis in patients with T2DM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.